The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development

International Heart Journal

Volumn 48, Issue 4, 2007, Pages 435-442

  Altin, Timucin ^a   Kilickap, Mustafa ^a   Tutar, Eralp ^a   Turhan, Sibel ^a   Atmaca, Yusuf ^a   Gulec, Sadi ^a   Oral, Dervis ^a   Erol, Cetin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

ACE inhibitors; Coronary collateral vessels; Coronary occlusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DISEASE DURATION; DRUG USE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 34648827875     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.435     Document Type: Article

References (29)

1. Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989; 117: 290-5.
2. Piek JJ, van Liebagen RA, Koch KT, Peters RJ, David GK. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 1997; 29: 275-82.
3. van Roycn N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001; 49: 543-53. (Review)
4. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochem Biophys Acta 1998; 1401: 187-94.
5. Otani A, Tagaki H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998; 82: 619-28.
6. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1419-24.
7. Itoh K Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth in response to angiotensin II. J Clin Invest 1993; 91: 2268-74.
8. Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of head failure. A report from the AIRE Study Investigators. Eur Heart J 1997; 18: 41-51.
9. Greenberg B, Quinones MA, Koilpillai C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995; 91: 2573-81.
10. Fabre JE, Rivard A, Magner M, Silver M, Isner JM. Tissue inhibition of angiotensin converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999; 99: 3043-9.
11. Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger T. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997; 29: 478-82.
12. Rentrop, KP, Cohen M Blanke H, Phillips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92.
13. Morbidelli L, Parenti A, Giovanelli L, Granger HJ, Ledda F, Ziche M. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol 1998; 124: 1286-92.
14. Miura S, Matsuo, Y, Saku K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 2003; 41: 1118-23.
15. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 1990; 259: R393-404. (Review)
16. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507-21. (Review)
17. Cohen M, Rentrop KP. Limitation of myocardial ischerma by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 74: 469-76.
18. Gosgnach W, Challah M, Could F, Michel JB, Battle T. Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. Cardiovasc Res 2000; 45: 486-92.
19. Miura S, Nishikawa H, Zhang B, et al. Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease. Circ J 2003; 67: 535-8.
20. Imaizumi S, Miura S, Nishikawa H, et al. Angiotensin II type 1 receptor blockers do not promote coronary collateral lateral circulation in patients with coronary artery disease. Hypertens 2006; 29: 135-41.
21. 1 receptor signaling modulates reparative angiogenesis induced by limb ischaemia. Br J Pharmacol 2002; 135: 87-92.
22. Sasaki K, Murohara T, Ikeda H, et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angoigenesis. J Clin Invest 2002; 109: 603-11.
23. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994; 89: 2273-82.
24. Horuichi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33: 613-21.
25. Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-42.
26. Johansen OE, Birkeland KI. Preventing macrovascular disease in patients with type 2 diabetes mellitus-Am J Cardiovasc Drugs 2003; 3: 283-97. (Review)
27. Pellinen TJ, Virtanen KS, Toivonen L, Heikkila J, Hekali P, Frick MH. Coronary collateral circulation. Clin Cardiol 1991; 14: 111-8.
28. Ilia R, Carmel S, Cafri C, Gueron M. Coronary collaterals in patients with normal and impaired left ventricular systolic function. Int J Cardiol 1998; 63: 151-3.
29. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974; 50: 831-7.